1. Home
  2. ULBI vs GBIO Comparison

ULBI vs GBIO Comparison

Compare ULBI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULBI
  • GBIO
  • Stock Information
  • Founded
  • ULBI 1990
  • GBIO 2016
  • Country
  • ULBI United States
  • GBIO United States
  • Employees
  • ULBI N/A
  • GBIO N/A
  • Industry
  • ULBI Industrial Machinery/Components
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULBI Miscellaneous
  • GBIO Health Care
  • Exchange
  • ULBI Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ULBI 128.6M
  • GBIO 29.5M
  • IPO Year
  • ULBI 1992
  • GBIO 2020
  • Fundamental
  • Price
  • ULBI $6.83
  • GBIO $5.59
  • Analyst Decision
  • ULBI Strong Buy
  • GBIO Buy
  • Analyst Count
  • ULBI 1
  • GBIO 4
  • Target Price
  • ULBI $14.00
  • GBIO $10.67
  • AVG Volume (30 Days)
  • ULBI 57.7K
  • GBIO 82.5K
  • Earning Date
  • ULBI 11-07-2025
  • GBIO 11-05-2025
  • Dividend Yield
  • ULBI N/A
  • GBIO N/A
  • EPS Growth
  • ULBI N/A
  • GBIO N/A
  • EPS
  • ULBI 0.19
  • GBIO N/A
  • Revenue
  • ULBI $178,853,000.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • ULBI $31.30
  • GBIO N/A
  • Revenue Next Year
  • ULBI $6.24
  • GBIO N/A
  • P/E Ratio
  • ULBI $35.65
  • GBIO N/A
  • Revenue Growth
  • ULBI 5.86
  • GBIO 61.15
  • 52 Week Low
  • ULBI $4.07
  • GBIO $3.00
  • 52 Week High
  • ULBI $10.09
  • GBIO $29.10
  • Technical
  • Relative Strength Index (RSI)
  • ULBI 44.92
  • GBIO 47.74
  • Support Level
  • ULBI $6.57
  • GBIO $5.63
  • Resistance Level
  • ULBI $7.02
  • GBIO $6.25
  • Average True Range (ATR)
  • ULBI 0.29
  • GBIO 0.32
  • MACD
  • ULBI 0.04
  • GBIO -0.11
  • Stochastic Oscillator
  • ULBI 31.71
  • GBIO 7.29

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: